Ju Jae-Woo, Nam Karam, Hong Hyunsook, Cheun Hyeon, Bae Jinyoung, Lee Seohee, Cho Youn Joung, Jeon Yunseok
Department of Anesthesiology and Pain Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
Department of Anesthesiology and Pain Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
J Clin Anesth. 2022 Aug;79:110693. doi: 10.1016/j.jclinane.2022.110693. Epub 2022 Feb 24.
The age, creatinine, and ejection fraction (ACEF) I and II scores are known to predict operative mortality after cardiac surgery. However, data from few cases of off-pump coronary artery bypass grafting (OPCAB) were considered during the development of these scores. This study aimed to validate and update the ACEF I and II scores for the prediction of in-hospital mortality after OPCAB.
Single-center retrospective observational study.
Tertiary university hospital.
All adult patients (≥18 years) who underwent isolated OPCAB between 2011 and 2020 were included in our analysis.
Predicted in-hospital mortality after OPCAB was calculated using ACEF and ACEF II scores. Performance of ACEF I and II scores in predicting in-hospital mortality after OPCAB was evaluated using receiver operating characteristics curves and calibration plots. Scores were recalibrated and modified using the closed testing procedure and multivariable fractional polynomial analysis.
In total, 1450 patients were analyzed. The ACEF I and II scores discriminated in-hospital mortality with the c-statistics of 0.86 and 0.83, respectively. The calibration plots revealed that both scores overestimated the risk of in-hospital mortality. The ACEF I score was recalibrated by re-estimating only the model intercept. The ACEF II score was modified by substituting hematocrit with left main coronary artery disease. The c-statistic of the updated ACEF II score increased to 0.86. Both the updated ACEF I and II scores were well-calibrated.
The ACEF I and II scores discriminated in-hospital mortality after OPCAB with excellent accuracy, although calibration properties were suboptimal. The updated scores showed even better discrimination and calibration. Thus, the ACEF I and ACEF II scores can be relatively straightforward and useful tools for prognostication of patients undergoing OPCAB.
年龄、肌酐和射血分数(ACEF)I和II评分已知可预测心脏手术后的手术死亡率。然而,在这些评分的制定过程中,很少有非体外循环冠状动脉搭桥术(OPCAB)病例的数据被纳入考虑。本研究旨在验证并更新ACEF I和II评分,以预测OPCAB术后的院内死亡率。
单中心回顾性观察研究。
三级大学医院。
纳入2011年至2020年间接受单纯OPCAB的所有成年患者(≥18岁)进行分析。
使用ACEF和ACEF II评分计算OPCAB术后预测的院内死亡率。使用受试者工作特征曲线和校准图评估ACEF I和II评分在预测OPCAB术后院内死亡率方面的表现。采用封闭检验程序和多变量分数多项式分析对评分进行重新校准和修正。
共分析了1450例患者。ACEF I和II评分对院内死亡率的区分度分别为c统计量0.86和0.83。校准图显示,这两个评分均高估了院内死亡风险。ACEF I评分通过仅重新估计模型截距进行重新校准。ACEF II评分通过用左主干冠状动脉疾病替代血细胞比容进行修正。更新后的ACEF II评分的c统计量增至0.86。更新后的ACEF I和II评分校准良好。
ACEF I和II评分对OPCAB术后院内死亡率的区分度很高,尽管校准性能欠佳。更新后的评分显示出更好的区分度和校准效果。因此,ACEF I和ACEF II评分可为接受OPCAB的患者提供相对直接且有用的预后评估工具。